Blueshift Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,729
| Closed | -$696K | – | 564 |
|
|
2024
Q4 | $696K | Buy |
+1,729
| New | +$696K | 0.25% | 103 |
|
|
2023
Q1 | – | Sell |
-1,263
| Closed | -$365K | – | 464 |
|
|
2022
Q4 | $365K | Buy |
+1,263
| New | +$365K | 0.17% | 177 |
|
|
2021
Q4 | – | Sell |
-9,671
| Closed | -$1.75M | – | 1246 |
|
|
2021
Q3 | $1.75M | Buy |
9,671
+3,749
| +63% | +$680K | 0.1% | 271 |
|
|
2021
Q2 | $1.19M | Buy |
5,922
+1,924
| +48% | +$388K | 0.07% | 312 |
|
|
2021
Q1 | $859K | Buy |
+3,998
| New | +$859K | 0.09% | 311 |
|
|
2019
Q4 | – | Sell |
-2,964
| Closed | -$502K | – | 1056 |
|
|
2019
Q3 | $502K | Buy |
+2,964
| New | +$502K | 0.08% | 373 |
|